• our science is driven by understanding and utilizing endogenous signalling pathways
  • our drug candidates are highly potent and stable analogues

Novel therapeutic strategy

OMEICOS Therapeutics is developing novel, first-in-class, orally available small molecules utilizing a new Mode of Action.
 
It is our goal to utilize our proprietary technology and knowledge of the body’s own omega-3 fatty acid metabolic processes for the development of therapeutics that benefit patients suffering from medically underserved diseases.